Items where authors include "Khokhar, F.A."

Article

Paller, A.S., Ramien, M. orcid.org/0000-0001-9191-3611, Cork, M.J. orcid.org/0000-0003-4428-2428 et al. (9 more authors) (2024) Low infection rates with long‐term dupilumab treatment in patients aged 6 months to 5 years: an open‐label extension study. Pediatric Dermatology. ISSN 0736-8046

Paller, A.S. orcid.org/0000-0001-6187-6549, Siegfried, E.C., Simpson, E.L. et al. (7 more authors) (2024) Dupilumab safety and efficacy up to 1 Year in children aged 6 months to 5 years with atopic dermatitis: results from a phase 3 open-label extension study. American Journal of Clinical Dermatology, 25 (4). pp. 655-668. ISSN 1175-0561

Paller, A.S., Siegfried, E.C., Cork, M.J. orcid.org/0000-0003-4428-2428 et al. (7 more authors) (2024) Infections in children aged 6 months to 5 years treated with dupilumab in a placebo-controlled clinical trial of moderate-to-severe atopic dermatitis. Pediatric Drugs, 26 (2). pp. 163-173. ISSN 1174-5878

Paller, A.S., Beck, L.A., Blauvelt, A. et al. (9 more authors) (2022) Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis—a pooled analysis of trial data. Pediatric Dermatology, 39 (2). pp. 187-196. ISSN 0736-8046

Paller, A.S., Wollenberg, A., Siegfried, E. et al. (12 more authors) (2021) Laboratory safety of dupilumab in patients aged 6–11 years with severe atopic dermatitis : results from a phase III clinical trial. Pediatric Drugs, 23 (5). pp. 515-527. ISSN 1174-5878

Paller, A.S., Siegfried, E.C., Thaçi, D. et al. (22 more authors) (2020) Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial. Journal of the American Academy of Dermatology, 83 (5). pp. 1282-1293. ISSN 0190-9622